scholarly article | Q13442814 |
P2093 | author name string | Maria Miteva | |
Francisco A Kerdel | |||
Magalys Vitiello | |||
Michael L Shelling | |||
Paolo Romanelli | |||
Emma L Lanuti | |||
P2860 | cites work | Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. | Q37020532 |
Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients | Q37037622 | ||
Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study | Q37172815 | ||
Cutaneous side effects of anti-tumor necrosis factor biologic therapy: a clinical review | Q37560336 | ||
Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis | Q37767889 | ||
Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series | Q79169980 | ||
P433 | issue | 8 | |
P921 | main subject | TNF inhibitor | Q1536078 |
generalized pustular psoriasis | Q5532501 | ||
pustulosis | Q7262033 | ||
P304 | page(s) | 40-41 | |
P577 | publication date | 2012-08-01 | |
P1433 | published in | The Journal of clinical and aesthetic dermatology | Q26842086 |
P1476 | title | A Case of Palmoplantar Pustulosis Induced by Certolizumab Pegol: New Anti-TNF-alpha Demonstrates the Same Class Effect | |
P478 | volume | 5 |
Q36904729 | Paradoxes in dermatology | cites work | P2860 |
Search more.